Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Gene therapy pharmacokinetic considerations

Mahato, R.I., Takakura, Y. and Hashida, M. (1997) Nonviral vectors for in vivo gene therapy Physicochemical and pharmacokinetic considerations. Crit. Rev. Ther. Drug Carrier Syst, 14 133-172. [Pg.356]

Table 22.1 Pharmacokinetic considerations for gene therapy agents [Adapted from Ledley TS, Ledley FD. 1994. Multicompartment numerical model of cellular events in the pharmacokinetics of gene therapies. Hum. Gene Ther. 5 679-691]... Table 22.1 Pharmacokinetic considerations for gene therapy agents [Adapted from Ledley TS, Ledley FD. 1994. Multicompartment numerical model of cellular events in the pharmacokinetics of gene therapies. Hum. Gene Ther. 5 679-691]...
Table 17.1 Pharmacokinetic considerations for gene therapy agents... Table 17.1 Pharmacokinetic considerations for gene therapy agents...
M. Nishikawa, Y. Takakura, M. Hashida, Pharmacokinetic considerations regarding non-viral cancer gene therapy. Cancer Sci. 99 (2008) 856-862. [Pg.38]

See other pages where Gene therapy pharmacokinetic considerations is mentioned: [Pg.136]    [Pg.355]    [Pg.736]    [Pg.1062]   
See also in sourсe #XX -- [ Pg.281 , Pg.287 ]



SEARCH



Gene pharmacokinetic considerations

Gene therapy

Pharmacokinetic considerations

Pharmacokinetics gene therapy

Pharmacokinetics therapy

© 2024 chempedia.info